MedPath

A study on the safety and efficacy of semaglutide in obese patients

Not Applicable
Conditions
Obsesity patients
Registration Number
JPRN-UMIN000053714
Lead Sponsor
Kitasato University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Severe anemia (Hb level < 10 g/dL) 2. Patients using implanted medical devices (such as pacemakers) 3. Patients with active malignant tumors 4. Participants for whom the principal investigator or collaborating investigator has deemed participation in this clinical study inappropriate 5. Pregnant women or women who may be pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath